DiCola K, Antosy A, Steinberg D
Contin Educ. 2024; 4(1):126-138.
PMID: 38774906
PMC: 11104308.
DOI: 10.5334/cie.92.
Walsh S, Mulraney M, McCarthy M, De Luca C
Health Qual Life Outcomes. 2024; 22(1):27.
PMID: 38519964
PMC: 10960388.
DOI: 10.1186/s12955-024-02241-2.
Gandy K, Hall L, Krull K, Esbensen A, Rubnitz J, Jacola L
Cancer Med. 2024; 13(3):e6842.
PMID: 38240104
PMC: 10905531.
DOI: 10.1002/cam4.6842.
Tejeda-Castellanos X, Sanchez-Medina C, Marquez-Gonzalez H, Alaniz-Arcos J, Ortiz-Cornejo M, Brito-Suarez J
BMC Pediatr. 2023; 23(1):513.
PMID: 37845644
PMC: 10578039.
DOI: 10.1186/s12887-023-04316-3.
Baughan N, Pell J, Mackay D, Clark D, King A, Fleming M
PLoS One. 2023; 18(7):e0286840.
PMID: 37494295
PMC: 10370705.
DOI: 10.1371/journal.pone.0286840.
Choroid plexus-CSF-targeted antioxidant therapy protects the brain from toxicity of cancer chemotherapy.
Jang A, Petrova B, Cheong T, Zawadzki M, Jones J, Culhane A
Neuron. 2022; 110(20):3288-3301.e8.
PMID: 36070751
PMC: 9588748.
DOI: 10.1016/j.neuron.2022.08.009.
Recommendations for the surveillance of education and employment outcomes in survivors of childhood, adolescent, and young adult cancer: A report from the International Late Effects of Childhood Cancer Guideline Harmonization Group.
Devine K, Christen S, Mulder R, Brown M, Ingerski L, Mader L
Cancer. 2022; 128(13):2405-2419.
PMID: 35435238
PMC: 9321726.
DOI: 10.1002/cncr.34215.
Social adjustment across the lifespan in survivors of pediatric acute lymphoblastic leukemia (ALL): a systematic review.
Cho S, Tromburg C, Forbes C, Tran A, Allapitan E, Fay-McClymont T
J Cancer Surviv. 2022; 17(4):1221-1237.
PMID: 34988754
DOI: 10.1007/s11764-021-01140-5.
Human placental extract ameliorates methotrexate-induced hepatotoxicity in rats via regulating antioxidative and anti-inflammatory responses.
Ghoneum M, El-Gerbed M
Cancer Chemother Pharmacol. 2021; 88(6):961-971.
PMID: 34505929
PMC: 8536621.
DOI: 10.1007/s00280-021-04349-4.
Psychological, educational, and social late effects in adolescent survivors of Wilms tumor: A report from the Childhood Cancer Survivor Study.
Foster R, Hayashi R, Wang M, Liu W, Mohrmann C, Howell R
Psychooncology. 2020; 30(3):349-360.
PMID: 33113206
PMC: 7965255.
DOI: 10.1002/pon.5584.
Neurocognitive outcomes in long-term survivors of Wilms tumor: a report from the St. Jude Lifetime Cohort.
Tonning Olsson I, Brinkman T, Hyun G, Banerjee P, Mulrooney D, Huang I
J Cancer Surviv. 2019; 13(4):570-579.
PMID: 31243647
PMC: 6679797.
DOI: 10.1007/s11764-019-00776-8.
Childhood leukemia survivors exhibit deficiencies in sensory and cognitive processes, as reflected by event-related brain potentials after completion of curative chemotherapy: A preliminary investigation.
Brace K, Lee W, Cole P, Sussman E
J Clin Exp Neuropsychol. 2019; 41(8):814-831.
PMID: 31156064
PMC: 6663575.
DOI: 10.1080/13803395.2019.1623865.
Evaluation of quality of life of healthy siblings of children with chronic disease.
Dinleyici M, Dagli F
Turk Pediatri Ars. 2019; 53(4):205-213.
PMID: 30872922
PMC: 6408193.
DOI: 10.5152/TurkPediatriArs.2018.6778.
Behavioral symptoms and psychiatric disorders in child and adolescent long-term survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.
Liu W, Cheung Y, Brinkman T, Banerjee P, Srivastava D, Nolan V
Psychooncology. 2018; 27(6):1597-1607.
PMID: 29521470
PMC: 5986588.
DOI: 10.1002/pon.4699.
Chronic Health Conditions and Neurocognitive Function in Aging Survivors of Childhood Cancer: A Report from the Childhood Cancer Survivor Study.
Cheung Y, Brinkman T, Li C, Mzayek Y, Srivastava D, Ness K
J Natl Cancer Inst. 2017; 110(4):411-419.
PMID: 29088360
PMC: 6059140.
DOI: 10.1093/jnci/djx224.
Self-Esteem and Academic Difficulties in Preadolescents and Adolescents Healed from Paediatric Leukaemia.
Tremolada M, Taverna L, Bonichini S, Basso G, Pillon M
Cancers (Basel). 2017; 9(6).
PMID: 28538707
PMC: 5483874.
DOI: 10.3390/cancers9060055.
Long-term brain structural magnetic resonance imaging and cognitive functioning in children treated for acute lymphoblastic leukemia with high-dose methotrexate chemotherapy alone or combined with CNS radiotherapy at reduced total dose to 12 Gy.
Zajac-Spychala O, Pawlak M, Karmelita-Katulska K, Pilarczyk J, Derwich K, Wachowiak J
Neuroradiology. 2017; 59(2):147-156.
PMID: 28074235
PMC: 5371615.
DOI: 10.1007/s00234-016-1777-8.
Feasibility of baseline neurocognitive assessment using Cogstate during the first month of therapy for childhood leukemia.
Sands S, Harel B, Savone M, Kelly K, Vijayanathan V, Greene Welch J
Support Care Cancer. 2016; 25(2):449-457.
PMID: 27726029
PMC: 5580925.
DOI: 10.1007/s00520-016-3422-9.
Predicting trajectories of behavioral adjustment in children diagnosed with acute lymphoblastic leukemia.
Sint Nicolaas S, Hoogerbrugge P, van den Bergh E, Custers J, Gameiro S, Gemke R
Support Care Cancer. 2016; 24(11):4503-13.
PMID: 27296238
PMC: 5031747.
DOI: 10.1007/s00520-016-3289-9.
Longitudinal Assessment of Neurocognitive Outcomes in Survivors of Childhood Acute Lymphoblastic Leukemia Treated on a Contemporary Chemotherapy Protocol.
Jacola L, Krull K, Pui C, Pei D, Cheng C, Reddick W
J Clin Oncol. 2016; 34(11):1239-47.
PMID: 26858334
PMC: 4872325.
DOI: 10.1200/JCO.2015.64.3205.